Silco Pharmaceuticals Income Statement

Financials in millions BDT. Fiscal year is July - June.

Millions BDT. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Revenue	-	410.1	464.7	559.47	601.06	733.65
Revenue Growth (YoY)	-	-11.75%	-16.94%	-6.92%	-18.07%	-20.17%
Cost of Revenue	-	278.25	318.76	372.72	433.3	521.74
Gross Profit	-	131.85	145.93	186.75	167.76	211.92
Selling, General & Admin	-	62.74	69.74	80.98	80.09	110.23
Other Operating Expenses	-	-0	-0	-0	-0	-0
Operating Expenses	-	72.68	78.75	89.27	88.37	114.95
Operating Income	-	59.17	67.18	97.48	79.39	96.96
Interest Expense	-	-1.04	-0.32	-0.53	-0.76	-
Interest & Investment Income	-	0.62	0.4	0.32	6.12	14.58
Other Non Operating Income (Expenses)	-	1.31	3.43	5.21	4.46	-0.64
EBT Excluding Unusual Items	-	60.07	70.69	102.48	89.21	110.9
Gain (Loss) on Sale of Investments	-	-0.72	18.56	6.48	0.42	-
Pretax Income	-	59.35	89.24	108.96	89.63	110.9
Income Tax Expense	-	13.47	20.02	24.51	4.98	27.73
Net Income	-	45.88	69.22	84.45	84.65	83.18
Net Income to Common	-	45.88	69.22	84.45	84.65	83.18
Net Income Growth	-	-33.72%	-18.03%	-0.23%	1.77%	-48.81%
Shares Outstanding (Basic)	102	104	104	104	104	104
Shares Outstanding (Diluted)	102	104	104	104	104	104
Shares Change (YoY)	-2.36%	-	-	-	-	28.88%
EPS (Basic)	-	0.44	0.67	0.81	0.82	0.80
EPS (Diluted)	-	0.44	0.67	0.81	0.82	0.80
EPS Growth	-	-33.72%	-18.03%	-0.23%	1.77%	-60.28%
Free Cash Flow	-	0.05	-1.47	62.95	-119.22	-23.45
Free Cash Flow Per Share	-	0.00	-0.01	0.61	-1.15	-0.23
Dividend Per Share	-	0.100	0.300	0.500	1.000	1.000
Dividend Growth	-	-66.67%	-40.00%	-50.00%	-	450.05%
Gross Margin	-	32.15%	31.40%	33.38%	27.91%	28.88%
Operating Margin	-	14.43%	14.46%	17.42%	13.21%	13.22%
Profit Margin	-	11.19%	14.90%	15.10%	14.08%	11.34%
Free Cash Flow Margin	-	0.01%	-0.32%	11.25%	-19.84%	-3.20%
EBITDA	-	147.77	153.9	172.16	153.98	175.65
EBITDA Margin	-	36.03%	33.12%	30.77%	25.62%	23.94%
D&A For EBITDA	-	88.59	86.72	74.68	74.59	78.69
EBIT	-	59.17	67.18	97.48	79.39	96.96
EBIT Margin	-	14.43%	14.46%	17.42%	13.21%	13.22%
Effective Tax Rate	-	22.70%	22.44%	22.49%	5.56%	25.00%
Advertising Expenses	-	3.55	3.79	4.84	6.2	12.07

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.